← Back to Search

INSPIRE Support Groups for Domestic Violence

N/A
Waitlist Available
Led By Tami P Sullivan, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Domestic Violence Service Provider client referred for support group services
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 9 weeks, 18 weeks
Awards & highlights

Study Summary

This trial will test a new group intervention to help survivors of intimate partner violence feel safe, supported and empowered. Weekly 90-min sessions will teach skills to identify abuse, safety-plan, and set goals. Outcomes will be compared to traditional support groups.

Who is the study for?
This trial is for individuals who are clients of domestic violence service providers and have been referred to join support group services. It's not specified who can't participate, so it may be open to a broad range of people affected by intimate partner violence.Check my eligibility
What is being tested?
The study is testing a new group intervention called INSPIRE, aimed at helping survivors of intimate partner violence. Participants will attend weekly sessions for 9 weeks, learning skills like safety planning and empowerment. This will be compared with traditional support groups.See study design
What are the potential side effects?
Since this trial involves support groups rather than medical treatments, there aren't typical side effects. However, discussing traumatic experiences could potentially cause emotional discomfort or distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 9 weeks, 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 9 weeks, 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in empowerment assessed using the Personal Progress Scale - Revised (PPS-R)
Change in safety-related empowerment assessed using the Measure of Victim Empowerment Related to Safety (MOVERS) Scale
Change in social support assessed using the Medical Outcomes Study Social Support (MOS-SS) Survey
+4 more
Secondary outcome measures
Change in Wellbeing assessed using the Quality of Life questionnaire
Change in Wellbeing assessed using the Rosenberg Self-Esteem Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: INSPIRE GroupExperimental Treatment1 Intervention
90-minute support group; 9 content sessions over 18 weeks; co-led by a professional facilitator and peer.
Group II: Intervention as Usual: Traditional Domestic Violence Support GroupActive Control1 Intervention
75-minute support group; 18-weeks; led by a domestic violence service provider counselor or advocate

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,737,659 Total Patients Enrolled
Tami P Sullivan, PhDPrincipal InvestigatorDepartment of Psychiatry, Yale School of Medicine

Media Library

INtervention Support groups: Peers Inspiring Resilience and Empowerment Clinical Trial Eligibility Overview. Trial Name: NCT05826041 — N/A
Domestic Violence Research Study Groups: INSPIRE Group, Intervention as Usual: Traditional Domestic Violence Support Group
Domestic Violence Clinical Trial 2023: INtervention Support groups: Peers Inspiring Resilience and Empowerment Highlights & Side Effects. Trial Name: NCT05826041 — N/A
INtervention Support groups: Peers Inspiring Resilience and Empowerment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826041 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any enrollment opportunities available for this investigation?

"The study, first published on March 23rd of this year, is not presently enrolling patients. On April 11th the trial was last updated and there are now 22 other trials actively seeking participants."

Answered by AI
~4 spots leftby Apr 2025